Background: Prostate cancer is one of the most common male cancers in Western countries and takes the third place in morbidity in Ukraine. It is a highly heterogeneous disease. Aim: To analyze relative expression levels of the TGFB1, IL1B, FOS, EFNA5, TAGLN, PLAU, and EPDR1 genes in malignant and non-malignant prostate tissues. Materials and Methods: Total RNA was isolated from 16 prostate adenomas, 37 prostate adenocarcinomas, and 29 conventionally normal prostate tissues. To analyze relative gene expression levels the quantitative real-time polymerase chain reaction was performed. Results: The significant alterations in the relative expression levels were found in all analyzed sample groups for 4 genes: FOS, EFNA5, IL1B, and TGFB1. We have found that FOS and EFNA5 were more frequently overexpressed in carcinomas with Gleason score ≤ 7, compared with adenomas. On contrary, PLAU expression levels were decreased more frequently in prostate cancers, compared with conventionally normal tissues. Noteworthy, we found positive correlation between IL1B expression level and PSA (for patients with slight PSA increase, no more than 20.0 ng/ml). Conclusion: The EFNA5, FOS, IL1B, PLAU, and TGFB1 genes that showed significant expression alterations in prostate tumors, compared with conventionally normal prostate tissue, may play role in prostate cancer development and should be further investigated.
Prostate cancer is t�e most frequently diagnosed male cancers in Western countries� taking t�e t�ird place in morbidity and t�e second place in mortality in Ukraine in t�e year ���4 [�� �]. Despite numerous studies t�at aimed to s�ed lig�t on t�e molecular mec�a-nisms� underlying initiation and subsequent progression of prostate tumors� t�e precise mec�anism and factors stimulating t�e fast transition to metastatic cancer are not yet fully understood. One of t�e key factors of t�ese pitfalls is a �ig� level of �eterogeneity of t�is malignancy. Prostate cancer is c�aracterized by not only interpatient �eterogeneity [�]� but more t�an a �alf of malignant prostate tumor of one patient contains several disease focuses [ 4� 5] . T�ese biological differences result in t�e differential prostate cancer-specific mortality rates [6] and make selection of t�e appropriate t�erapy for patients t�e real c�allenge [�] .
Earlier� we �ave analyzed t�e gene expression pattern in t�e prostate cancer cell lines� using a quantitative real-time polymerase c�ain reaction �qPCR� microarrays� in order to find differentially expressed genes and deduce t�e possible signaling pat�ways� involved in transformation into androgen-independent type. T�e studied prostate cancer cell lines LNCaP� DU�45� and PC� s�owed different invasion and metastatic potential; LNCaP cells are androgen-dependent� w�ile PC� -androgen-independent [8� �]. Based on results of t�ese experiments� t�e following genes� namely TAGLN� EFNA5� IL1B� PLAU, TGFB1� EPDR1� and FOS were selected to study t�e clinical samples. T�ese genes are involved in different cellular pat�ways� EFNA5, TAGLN, and EPDR1� for example� play a role in cell-cell and cell-matrix ad�esion� t�at are diminis�ed during tumor progression [��] . Additionally� TAGLN is involved in t�e p5� pat�way [��] and IL1B -in t�e NF-κB pat�way [��] . It was s�own t�at PLAU participates in t�e control on invasion and metastasis [��] . It was reported also� t�at TGFB1 could promote angiogenesis and t�e epit�elial to mesenc�ymal cell transition [�4] . T�e transcriptional factor FOS is involved in different cellular processes� including inflammation [�5] .
In t�e present study we aimed to validate t�e previously obtained data and to analyze relative expression �RE� levels of t�e TGFB1� IL1B� FOS� EFNA5� TAGLN� PLAU, and EPDR1 genes in malignant and non-malignant prostate tissues.
MATERIALS AND METHODS
Tissue samples. Prostate adenoma and carcinoma tissue specimens from perip�eral zone� as well as conventionally normal tissues �CNT� from opposite transitional zone of prostate were collected after surgical resection of prostate tumors from patients at t�e Institute of Urology of National Academy of �edical Sciences of Ukraine and National Cancer Institute �Kyiv� Ukraine� and were immediately frozen in liquid nitrogen. In total� �6 samples of benign prostatic �yperplasia �adenoma� and �� adenocarcinoma samples were collected; among t�em �� samples were supplemented wit� t�e paired CNT �Table ��. Among adenocarcinoma samples t�ere were �� samples of Gleason score �Gl� ≤ � and �4 samples of Gl > �. Twenty-nine samples represented t�e stages I and II; eig�t samples were of t�e stages III and IV. T�e samples were collected in accordance wit� t�e Declaration of Helsinki and approved by t�e guidelines issued by t�e Et�ic Committee of t�e Institute of Urology and National Cancer Institute� Kyiv� Ukraine. Also� all patients gave written informed consent. Isolation of the total RNA. Total RNA samples from t�e frozen tissues were isolated� using TRI Reagent �Sigma-Aldric�� USA�� according to t�e manufacturer's instructions. T�e quality of t�e total RNA was assessed� using electrop�oresis; purity was analyzed� using t�e NanoDrop ���� spectrop�otometer �T�ermo Fis�er Scientific� USA�. RNA was stored t�en at �8� °C.
Synthesis of the first strand cDNA. T�e isolated total RNA was treated wit� DNAse I �T�ermo Scientific� USA�. cDNA was synt�esized from � µg of total RNA� using t�e RevertAid H �inus First Strand cDNA Synt�esis kit �T�ermo Scientific� USA�. All procedures were performed� according to t�e manufacturer's instructions.
Quantitative real-time PCR. qPCR was performed� using t�e �axima SYBR Green/ROX qPCR �aster �ix �T�ermo Scientific� USA� and CFX�6 Touc� Real-time PCR Detection System �Bio-Rad� USA�� according to t�e manufacturer's instructions. T�e following conditions were used: initial denaturation at �5 °C for �� m� followed by 4� cycles of denaturation at �5 °C for �5 s� annealing at 6� °C for �� s� and extension at �� °C for �� s. Primers used in qPCR are s�own in Table �. All data were analyzed� using qRT-PCR Data Analysis Software �Bio-Rad� USA�. T�is integrated web-based software package automatically calculates � �ΔΔCt -based relative quantities from t�e uploaded raw t�res�old cycle data. T�e TBP gene was used as a reference gene [�6] . T�e inter-run calibration was used to correct run-to-run differences. As calibrator� a mixture of two cDNA from adenoma samples was used. T�e Livak met�od � �ΔΔCt of calculation of gene RE was used. Specific amplification was confirmed� using t�e melting curve met�od.
Statistical analysis. T�e Kolmogorov -Smirnov and Lilliefors tests were used for assessing normality of distribution for levels of RE. Contingency tables were used for assessment of association of RE levels in groups of adenomas� CNT� and carcinomas wit� t�e Gl and levels of t�e PSA. T�e permutation based Fis�-er's exact test was used for estimation of significance. T�e Wilcoxon test was used to analyze differences in RE levels between carcinomas and matc�ed CNT. Logistic regression was used to analyze associations between RE levels and clinical data of patients. p-values < �.�5 were considered as t�e statistically significant [��] . All statistical procedures were performed� using t�e STATISTICA ��.� software �StatSoft� USA� and also t�e Open Source Epidemiologic Statistics for Public Healt� �available at �ttp://www.openepi.com/�. Also t�e software ORIGIN 8.5 �OriginLab� USA� was used.
RESULTS

Levels of RE of t�e EFNA5� EPDR1� FOS� IL1B� PLAU�
TAGLN� TGFB1 genes in comparison wit� TBP were assessed in all t�e samples �Fig. ��. In group of patients wit� adenomas a median age was 66.5 years� in t�e range 6���� years. In group of patients wit� adenocarcinomas median age was 6� years� in t�e range 48�8� years. For RE values descriptive statistics was performed �Fig. ��. We observed abnormal distributions in RE for all genes� except FOS� TAGLN, and EPDR1 in carcinomas and for IL1B in CNT� according to Kolmogorov -Smirnov and Lilliefors analysis. �oreover� we found t�at mean and median values of RE of TAGLN� EFNA5, and EPDR1 genes in adenomas were quite similar. Notewort�y� RE of all t�e genes s�owed t�e �ig� level of dispersion in adenomas� carcinomas� and CNT: for example� range of FOS RE in CNT was �.��8��85.8��. Besides t�at� standard deviation values of t�e RE of t�e all genes in CNT� carcinoma and adenoma groups were quite �ig�. For example� RE of t�e FOS gene was even �ig�er t�an values of medians: �E = �.�8� in carcinomas� w�ile SD = ��.6��.
To analyze t�e possible association of RE levels in different prostate tumors wit� contingency tables� RE levels and clinical data were divided into nominal meanings. T�us� RE levels were divided into � nominal meanings: � st -wit�out alterations �RE levels were in t�e range �.4���.���� � nd -wit� decreased RE �RE ≤ �.4� and � rd -wit� increased RE �RE ≥ �.��. Contingency table was created� w�ere in t�e rows t�ere are nominal meanings of RE and in t�e columns t�ere are nominal meanings of groups �Table ��.
It is well accepted t�at Gl is used for t�e classification of prostate cancers. As described in t�e European Association of Urology guidelines� patients wit� localized or locally advanced prostate cancer wit� Gl �ig�er t�an � are in t�e group of a �ig�-risk of recurrence [�8]. Because of t�at� 
Experimental Oncology ��� �������� ���� �June� ��� �������� ���� �June� �June� ��� we created t�e contingency table� w�ere in t�e rows t�ere are t�e nominal meanings of RE and in t�e columns t�ere are nominal meanings of carcinoma samples wit� Gl ≤ � �n = ��� and > � �n = �4� �Table 4�. We analyzed t�e RE in t�e paired carcinoma samples� compared wit� CNT in order to find associations in groups wit� different nominal meanings of Gl. T�erefore� we used t�e contingency table� w�ere in t�e rows t�ere are t�e nominal meanings of RE and in t�e columns t�ere are t�e nominal meanings of carcinoma samples wit� Gl ≤ � �n = �4� and > � �n = �5�. T�e contingency table was generated in order to analyze associations in RE levels in t�e group of carcinomas compared wit� CNT and levels of t�e PSA. In t�e rows t�ere
nd -wit� �ig� increase of PSA level �n = �4� range ��.����6.��. We do not s�ow t�ese tables� because no significant alterations in analyzed groups were found.
Based on t�e analysis of t�e data presented in Table �� we found 4 genes: FOS �p = �.������ EFNA5 �p = �.������ IL1B �p = �.��8��� and TGFB1 �p = �.����� t�at s�ow statistically significant alterations in frequencies of samples wit� altered RE between adenomas� carcinomas� and CNT. T�e significant c�anges were observed between adenomas and carcinomas in RE of FOS �p = �.���6� and EFNA5 �p = �.��4��. �oreover� we found RE alterations between carcinomas and CNT for TGFB1 gene �p = �.�����. Also we found alterations w�en comparing adenomas and CNT in RE of t�e FOS �p = �.���5�� IL1B �p = �.��6��� TGFB1 �p = �.��8��� and EFNA5 �p = �.��84� genes. Notewort�y� after t�e analysis of t�e Table 4 data� no differences in frequencies of samples wit� altered RE in nominal meanings wit� different Gl was found. However� t�e FOS �p = �.���4� and EFNA5 �p = �.����� genes s�owed altered RE between carcinomas and ade nomas. Particularly� t�ere were differences between adenomas and carcinomas wit� t�e Gl ≤ � �FOS p = �.����� EFNA5 p = �.���4�.
It is well known� as we mentioned already� t�at prostate cancer is �ig�ly �eterogeneous genetically and also� tumor even in patient could be multifocal [��] . T�e molecular nature of suc� �eterogeneity is still not c�arac-terized. T�erefore� it is important to s�ow any differences between tumor and CNT derived from t�e same prostate. As one of factors t�at may vary� we �ave c�osen t�e gene RE levels. We compared t�e RE values in t�e paired carcinoma -CNT samples� using t�e Wilcoxon test� and found t�e differential RE of t�e PLAU �p = �.��88� gene. Consequently� we calculated t�e RE fold c�ange in t�e paired carcinoma -CNT samples. T�e fold c�ange two or more times was considered as significant [��] . We found t�at RE was decreased in ��.6% of carcinomas compared wit� CNT� w�ile RE was increased in 6.�% of samples for TGFB1; ��.6% and ��.�%� respectively� -for IL1B; ��.8% and �4.�% -for FOS; ��.�% and 6.�% -for EFNA5; �4.5% and �4.�% -for TAGLN; ��.�% and ��.�% -for PLAU� and ��.�% and ��.8% -for EPDR1.
We did not find any statistically significant associations� using t�e permutation Fis�er's exact test in t�e RE levels between carcinomas and CNT and Gl� nor did we found for RE and levels of t�e PSA. �oreover� we did not find correlations between mentioned above groups� using t�e Spearman test. However� we found moderate direct correlations between all genes� except FOS ��.4���.6��. In patients wit� t�e slig�t increase of t�e PSA levels �no more t�an ��.� ng/ml� we found t�e positive correlation between RE of IL1B gene and PSA level �non-parametric regression analysis: OR = �.�; p = �.�����.
DISCUSSION
We observed a �ig� level of dispersion of t�e RE values for all t�e genes in all analyzed groups. It could be due to genetic �eterogeneity t�at takes place not only in pros- 2 -significant changes between adenomas and CNT; 3 -significant changes between carcinomas and CNT. In bold numbers marked sample frequencies with significant changes in groups. I  12  9  8  II  1  5  4  III  3  9  2  EPDR1  I  12  13  8  II  3  8  6  III  1 2 . RE in t�e t�ree sample groups� namely adenomas �red color�� carcinomas �green color�� and CNT �blue color� for genes: a� TAGLN� b� EFNA5� c� IL1B� d� PLAU� e� TGFB1� f� EPDR1� and g� FOS. T�e data are presented as box plots� w�ere t�e bottom and top rectangles define t�e first and t�ird quartile� respectively. T�e line across t�e box is t�e median. T�e w�iskers represent minimum and maximum and outliers are depicted by asterisks tate cancers� but also in adenomas and CNT. Probably� t�e investigated genes are differently regulated at t�e different conditions� w�ic� may depend on individual �ormonal state. Also� t�is mig�t be due to a complex mixture of cell pulls t�at differ not only by t�e origin �stromal and epit�e-lial�� but also by various stages of progression in individual samples [��] . T�us� t�e �istological tissue analysis prior experimental part assessing gene expression� is crucial and very important. As was discussed above� we found significant differences of RE levels for a set of genes� namely FOS� EFNA5� IL1B, and TGFB1, w�en compared samples of adenomas� carcinomas� and CNT. RE of FOS was increased frequently in carcinomas ��5 out of ���� compared wit� adenomas �� out of �6� and in all CNT� compared wit� adenomas �� out of �6�. . According to our results� t�e possible FOS activation in CNT could be due to t�e tumor impact on surrounding tissues; alternatively� it is due to t�e mixture of normal and cancer cells in CNT. Increased RE of EFNA5 was observed more frequently in carcinomas ��� out of ���� compared wit� adenomas �� out of �6�. Similar results were observed in CNT ��8 out of ���� compared wit� adenomas �� out of �6�. T�is gene encodes ep�rin-A5. It is a member of t�e ep�rin gene family� w�ic� plays role in cell ad�esion [�8]. It was s�own t�at EFNA5 was decreased in c�ondrosar-comas [��] and gliomas� compared wit� normal tissues. It acts as a tumor suppressor in gliomas� regulating negatively t�e epidermal growt� factor receptor [��] . Hence� t�e increased RE of EFNA5 in carcinomas points out t�e possible activation of EFNA5 associated signaling pat�-way� leading to subsequent aberrations in cell ad�esion in adenomas and carcinomas.
T�e increased RE levels of t�e IL1B gene were more frequently detected in CNT ��� out of ��� compared wit� adenomas �4 out of �6�. It may be due to general inflammation in prostate gland t�at is often associated wit� carcinogenesis. T�e similar tendency �but not significant� was found in carcinomas ��4 samples from ��� compared wit� adenomas �4 samples from �6� t�at supports our �ypot�esis. Our data suggest t�at t�e �ig�er PSA levels �but no more t�an ��.� ng/ml� correlated wit� increased RE of t�e IL1B gene. According to our results� t�e prostate cancer patients s�owing increased IL1B RE levels may be at t�e intermediate risk for bioc�emical recurrence� as described in t�e guidelines of t�e European Association of Urology.
At t�e ot�er �and� IL1B encodes one of t�e proinflammatory interleukins t�at is usually elevated in prostatic secretions of t�e patients wit� t�e c�ronic prostatitis [��] . It may be a valuable marker of inflammation in benign prostate �yperplasia [��] . T�us� furt�er investigations on a larger group of adenomas s�ould be performed. Our results support an idea t�at t�e NF-κB signaling pat�way is activated in bot�� carcinomas and in CNT� because IL1B is one of activators of t�e NF-κB pat�way [��] .
RE levels of TGFB1 were diminis�ed in adenomas more frequent �6 out of �6� t�an in CNT �� out of ���. Also� RE alterations �bot�� increase and decrease� was found more frequently in carcinomas ��� out of ��� compared wit� CNT �� out of ���. T�is gene encodes t�e transforming growt� factor beta �� regulating cell differentiation� proliferation� migration� and apoptosis [�4] . It plays t�e opposite roles in different types of prostate tumors: it acts as a growt� in�ibitor in normal tissues and early stage tumors [�5] and as a promoter in advanced prostate cancers [�6]. T�e opposite direction of alterations in RE levels of TGFB1 in carcinomas compared wit� CNT could be due to variations of individuals� reflecting different stages of disease. T�e similar c�anges in RE of t�e FOS� EFNA5, and IL1B genes in carcinomas and CNT could be due to �eterogeneity of bot�� cancers and CNT� i.e. cancer tissue may contain some proportion of normal cells� and vice versa. Notewort�y� RE of t�e PLAU gene were frequently decreased in carcinomas� compared wit� t�e paired CNT samples. T�is s�ould be validated on t�e larger groups of patients as well. No correlation was found between RE and Gl and/ or PSA level. No significant differences of RE alteration frequencies was detected in carcinomas wit� Gl ≤ � and > �� in contrast wit� comparison of adenomas and carcinomas wit� Gl ≤ � for FOS and EFNA5 genes. RE of t�e FOS gene were frequently increased in carcinomas wit� Gl ≤ � compared wit� adenomas. RE of t�e EFNA5 gene were altered in t�e majority of cases �bot�� decreased and increased� in t�e same comparison groups. T�e investigation of t�e possible molecular mec�anisms of t�e involvement of t�e FOS and EFNA5 in prostate cancer pat�ogenesis requires t�e furt�er experimental work. A nonparametric regression analysis �as s�own t�e significant correlation of t�e increased RE level of IL1B in carcinomas compared wit� CNT and t�e PSA level t�at may be used as an additional risk factor for t�e patients wit� intermediate risk of bioc�emical recurrence. However� t�is s�ould be validated on t�e larger patient groups.
Summarizing� results of t�e present work correspond to t�e earlier findings� obtained wit� cell lines [8� �]. Currently� we found t�e significant c�anges in RE for 5 out of � genes� comparing malignant and non-malignant prostate tissues� namely for EFNA5� FOS� IL1B� PLAU� and TGFB1. T�us� t�e PLAU gene is expressed at t�e lower levels in carcinomas� compared wit� t�e paired CNT� w�ic� is in agreement wit� our data on LNCaP and DU�45� compared wit� PNT� cells.
CONCLUSION
In t�e present work we �ave found t�e significant alterations in t�e RE levels of t�e FOS� EFNA5� IL1B, and TGFB1 genes in prostate tumors� comparing to CNT. We �ave found t�at FOS and EFNA5 were more frequently overexpressed in carcinomas wit� Gl ≤ �� compared wit� adenomas. On contrary� PLAU expresExperimental Oncology ��� �������� ���� �June� ��� �������� ���� �June� �June� ��� sion levels were decreased more frequently in prostate cancers� compared wit� CNT. Notewort�y� we found positive correlation between IL1B expression level and PSA for patients wit� slig�t PSA increase. T�e EFNA5� FOS� IL1B� PLAU, and TGFB1 genes t�at s�owed significant expression alterations in prostate tumors� compared wit� CNT� may play role in prostate cancer development and s�ould be furt�er investigated.
